BioCentury | Nov 24, 2008
Clinical News

Undisclosed intranasal compound: Phase II started

...compound was developed using the CPE-215 drug delivery technology from CPEX, which spun out from Bentley Pharmaceuticals Inc....
BioCentury | Aug 18, 2008
Clinical News

Undisclosed intranasal compound: Phase I started

...compound was developed using the CPE-215 drug delivery technology from CPEX, which spun out from Bentley Pharmaceuticals Inc....
BioCentury | Aug 11, 2008
Company News

CPEX, Serenity deal

...commercialization. CPEX is eligible for royalties. Further terms were not disclosed. CPEX spun out of Bentley Pharmaceuticals Inc....
BioCentury | Jul 28, 2008
Company News

Bentley Pharma, Teva deal

...following the spin-off of its drug delivery business earlier this month (see BioCentury, July 7). Bentley Pharmaceuticals Inc....
BioCentury | Jul 7, 2008
Company News

Bentley Pharma drug delivery news

...vote on whether to approve the acquisition on July 22 (see BioCentury, Oct. 29, 2007). Bentley Pharmaceuticals Inc....
BioCentury | Feb 18, 2008
Clinical News

Nasulin intranasal insulin: Preliminary Phase II data

...in Asia, Africa and the Middle East, while Dong Sung has rights in South Korea. Bentley Pharmaceuticals Inc....
BioCentury | Nov 19, 2007
Company News

Noven management update

...Endocrine Hired: Michael Price as VP and CFO, former VP, CFO, treasurer and secretary at Bentley Pharmaceuticals Inc....
BioCentury | Oct 29, 2007
Company News

Bentley Pharma drug delivery news

...sales of $100.6 million and 1H07 sales of $57.5 million. Deutsche Bank will advise BNT. Bentley Pharmaceuticals Inc....
BioCentury | Jul 2, 2007
Clinical News

Nasulin intranasal insulin: Interim Phase II data

...BioCentury, May 2, 2005). Eli Lilly and Co. (LLY, Indianapolis, Ind.) markets Humulin and Humalog. Bentley Pharmaceuticals Inc....
BioCentury | Apr 23, 2007
Clinical News

Nasulin intranasal insulin: Phase II started

...product in Asia, Africa and the Middle East in 2005 (see BioCentury, Nov. 21, 2005). Bentley Pharmaceuticals Inc....
Items per page:
1 - 10 of 34
BioCentury | Nov 24, 2008
Clinical News

Undisclosed intranasal compound: Phase II started

...compound was developed using the CPE-215 drug delivery technology from CPEX, which spun out from Bentley Pharmaceuticals Inc....
BioCentury | Aug 18, 2008
Clinical News

Undisclosed intranasal compound: Phase I started

...compound was developed using the CPE-215 drug delivery technology from CPEX, which spun out from Bentley Pharmaceuticals Inc....
BioCentury | Aug 11, 2008
Company News

CPEX, Serenity deal

...commercialization. CPEX is eligible for royalties. Further terms were not disclosed. CPEX spun out of Bentley Pharmaceuticals Inc....
BioCentury | Jul 28, 2008
Company News

Bentley Pharma, Teva deal

...following the spin-off of its drug delivery business earlier this month (see BioCentury, July 7). Bentley Pharmaceuticals Inc....
BioCentury | Jul 7, 2008
Company News

Bentley Pharma drug delivery news

...vote on whether to approve the acquisition on July 22 (see BioCentury, Oct. 29, 2007). Bentley Pharmaceuticals Inc....
BioCentury | Feb 18, 2008
Clinical News

Nasulin intranasal insulin: Preliminary Phase II data

...in Asia, Africa and the Middle East, while Dong Sung has rights in South Korea. Bentley Pharmaceuticals Inc....
BioCentury | Nov 19, 2007
Company News

Noven management update

...Endocrine Hired: Michael Price as VP and CFO, former VP, CFO, treasurer and secretary at Bentley Pharmaceuticals Inc....
BioCentury | Oct 29, 2007
Company News

Bentley Pharma drug delivery news

...sales of $100.6 million and 1H07 sales of $57.5 million. Deutsche Bank will advise BNT. Bentley Pharmaceuticals Inc....
BioCentury | Jul 2, 2007
Clinical News

Nasulin intranasal insulin: Interim Phase II data

...BioCentury, May 2, 2005). Eli Lilly and Co. (LLY, Indianapolis, Ind.) markets Humulin and Humalog. Bentley Pharmaceuticals Inc....
BioCentury | Apr 23, 2007
Clinical News

Nasulin intranasal insulin: Phase II started

...product in Asia, Africa and the Middle East in 2005 (see BioCentury, Nov. 21, 2005). Bentley Pharmaceuticals Inc....
Items per page:
1 - 10 of 34